The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study

OBJECTIVE: Neoadjuvant chemotherapy (NAC) is currently used in both early stage and locally advanced breast cancers. The survival benefits of standard vs. non-standard NAC cycles are still unclear. This study aimed to investigate the relationship between NAC cycles and survival based on real world d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Litong, Pang, Zhiyuan, Wang, Mozhi, Wang, Mengshen, Sun, Xiangyu, Cui, Mingke, Zheng, Yanfu, Li, Xinyan, Dong, Haoran, Zhang, Qiang, Xu, Yingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196050/
https://www.ncbi.nlm.nih.gov/pubmed/34633775
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196050/
https://www.ncbi.nlm.nih.gov/pubmed/34633775
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0800

Ejemplares similares